ArticleOncology and therapy2025

Progression-Free Survival Under Immune Checkpoint Inhibitors for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Cohort Study.

Paul Boré et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.